0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Paclitaxel Injection Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-18136
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Paclitaxel Injection Market Insights and Forecast to 2028

Global Paclitaxel Injection Market Insights and Forecast to 2028

Code: QYRE-Auto-18136
Report
January 2022
113 Pages
QYResearch
Region: Global, China,
Description
Table of Content
Tables & Figures
Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.
Market Analysis and Insights: Global Paclitaxel Injection Market

Due to the COVID-19 pandemic, the global Paclitaxel Injection market size is estimated to be worth US$ 3791.6 million in 2022 and is forecast to a readjusted size of US$ 7130.2 million by 2028 with a CAGR of 11.1% during the review period.

Fully considering the economic change by this health crisis, 5ml,30mg accounting for % of the Paclitaxel Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Ovarian Cancer segment is altered to an % CAGR throughout this forecast period.
Global Paclitaxel Injection key players include Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Luye Pharma, etc. Global top five players hold a share about 80%.
Europe is the largest market, with a share about 25%, followed by North America and China, having a total share about 40 percent.
In terms of product, 5ml,30mg is the largest segment, with a share about 75%. And in terms of application, the largest application is Ovarian Cancer, followed by Breast Cancer, Cervical Cancer, Pancreatic Cancer.
Global Paclitaxel Injection Scope and Segment
Paclitaxel Injection market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Paclitaxel Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

5ml,30mg
10ml,60mg
16.7ml,100mg
25ml,150mg
50ml,300mg

Segment by Application

Ovarian Cancer
Breast Cancer
Cervical Cancer
Pancreatic Cancer
Other

BY COMPANY

Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Paclitaxel Injection Product Introduction
1.2 Market by Type
1.2.1 Global Paclitaxel Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 5ml,30mg
1.2.3 10ml,60mg
1.2.4 16.7ml,100mg
1.2.5 25ml,150mg
1.2.6 50ml,300mg
1.3 Market by Application
1.3.1 Global Paclitaxel Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Cervical Cancer
1.3.5 Pancreatic Cancer
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Paclitaxel Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Paclitaxel Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Paclitaxel Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Paclitaxel Injection Sales by Region
2.4.1 Global Paclitaxel Injection Sales by Region (2017-2022)
2.4.2 Global Sales Paclitaxel Injection by Region (2023-2028)
2.5 Global Paclitaxel Injection Revenue by Region
2.5.1 Global Paclitaxel Injection Revenue by Region (2017-2022)
2.5.2 Global Paclitaxel Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Paclitaxel Injection Sales by Manufacturers
3.1.1 Global Top Paclitaxel Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Paclitaxel Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Paclitaxel Injection in 2021
3.2 Global Paclitaxel Injection Revenue by Manufacturers
3.2.1 Global Paclitaxel Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Paclitaxel Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Paclitaxel Injection Revenue in 2021
3.3 Global Paclitaxel Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Paclitaxel Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Paclitaxel Injection Sales by Type
4.1.1 Global Paclitaxel Injection Historical Sales by Type (2017-2022)
4.1.2 Global Paclitaxel Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Paclitaxel Injection Sales Market Share by Type (2017-2028)
4.2 Global Paclitaxel Injection Revenue by Type
4.2.1 Global Paclitaxel Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Paclitaxel Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Paclitaxel Injection Revenue Market Share by Type (2017-2028)
4.3 Global Paclitaxel Injection Price by Type
4.3.1 Global Paclitaxel Injection Price by Type (2017-2022)
4.3.2 Global Paclitaxel Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Paclitaxel Injection Sales by Application
5.1.1 Global Paclitaxel Injection Historical Sales by Application (2017-2022)
5.1.2 Global Paclitaxel Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Paclitaxel Injection Sales Market Share by Application (2017-2028)
5.2 Global Paclitaxel Injection Revenue by Application
5.2.1 Global Paclitaxel Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Paclitaxel Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Paclitaxel Injection Revenue Market Share by Application (2017-2028)
5.3 Global Paclitaxel Injection Price by Application
5.3.1 Global Paclitaxel Injection Price by Application (2017-2022)
5.3.2 Global Paclitaxel Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Paclitaxel Injection Market Size by Type
6.1.1 North America Paclitaxel Injection Sales by Type (2017-2028)
6.1.2 North America Paclitaxel Injection Revenue by Type (2017-2028)
6.2 North America Paclitaxel Injection Market Size by Application
6.2.1 North America Paclitaxel Injection Sales by Application (2017-2028)
6.2.2 North America Paclitaxel Injection Revenue by Application (2017-2028)
6.3 North America Paclitaxel Injection Market Size by Country
6.3.1 North America Paclitaxel Injection Sales by Country (2017-2028)
6.3.2 North America Paclitaxel Injection Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Paclitaxel Injection Market Size by Type
7.1.1 Europe Paclitaxel Injection Sales by Type (2017-2028)
7.1.2 Europe Paclitaxel Injection Revenue by Type (2017-2028)
7.2 Europe Paclitaxel Injection Market Size by Application
7.2.1 Europe Paclitaxel Injection Sales by Application (2017-2028)
7.2.2 Europe Paclitaxel Injection Revenue by Application (2017-2028)
7.3 Europe Paclitaxel Injection Market Size by Country
7.3.1 Europe Paclitaxel Injection Sales by Country (2017-2028)
7.3.2 Europe Paclitaxel Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Paclitaxel Injection Market Size by Type
8.1.1 Asia Pacific Paclitaxel Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Paclitaxel Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Paclitaxel Injection Market Size by Application
8.2.1 Asia Pacific Paclitaxel Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Paclitaxel Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Paclitaxel Injection Market Size by Region
8.3.1 Asia Pacific Paclitaxel Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Paclitaxel Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Paclitaxel Injection Market Size by Type
9.1.1 Latin America Paclitaxel Injection Sales by Type (2017-2028)
9.1.2 Latin America Paclitaxel Injection Revenue by Type (2017-2028)
9.2 Latin America Paclitaxel Injection Market Size by Application
9.2.1 Latin America Paclitaxel Injection Sales by Application (2017-2028)
9.2.2 Latin America Paclitaxel Injection Revenue by Application (2017-2028)
9.3 Latin America Paclitaxel Injection Market Size by Country
9.3.1 Latin America Paclitaxel Injection Sales by Country (2017-2028)
9.3.2 Latin America Paclitaxel Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Paclitaxel Injection Market Size by Type
10.1.1 Middle East and Africa Paclitaxel Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Paclitaxel Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Paclitaxel Injection Market Size by Application
10.2.1 Middle East and Africa Paclitaxel Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Paclitaxel Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Paclitaxel Injection Market Size by Country
10.3.1 Middle East and Africa Paclitaxel Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Paclitaxel Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Overview
11.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bristol-Myers Squibb Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bristol-Myers Squibb Recent Developments
11.2 Celgene Corporation
11.2.1 Celgene Corporation Corporation Information
11.2.2 Celgene Corporation Overview
11.2.3 Celgene Corporation Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Celgene Corporation Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Celgene Corporation Recent Developments
11.3 Hospira
11.3.1 Hospira Corporation Information
11.3.2 Hospira Overview
11.3.3 Hospira Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Hospira Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Hospira Recent Developments
11.4 Biological E.
11.4.1 Biological E. Corporation Information
11.4.2 Biological E. Overview
11.4.3 Biological E. Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Biological E. Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biological E. Recent Developments
11.5 Taj Accura
11.5.1 Taj Accura Corporation Information
11.5.2 Taj Accura Overview
11.5.3 Taj Accura Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Taj Accura Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Taj Accura Recent Developments
11.6 Khandelwal Laboratories
11.6.1 Khandelwal Laboratories Corporation Information
11.6.2 Khandelwal Laboratories Overview
11.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Khandelwal Laboratories Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Khandelwal Laboratories Recent Developments
11.7 Luye Pharma
11.7.1 Luye Pharma Corporation Information
11.7.2 Luye Pharma Overview
11.7.3 Luye Pharma Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Luye Pharma Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Luye Pharma Recent Developments
11.8 Beijing Youcare
11.8.1 Beijing Youcare Corporation Information
11.8.2 Beijing Youcare Overview
11.8.3 Beijing Youcare Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Beijing Youcare Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Beijing Youcare Recent Developments
11.9 Beijing Union
11.9.1 Beijing Union Corporation Information
11.9.2 Beijing Union Overview
11.9.3 Beijing Union Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Beijing Union Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Beijing Union Recent Developments
11.10 Haiyao
11.10.1 Haiyao Corporation Information
11.10.2 Haiyao Overview
11.10.3 Haiyao Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Haiyao Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Haiyao Recent Developments
11.11 Chuntch
11.11.1 Chuntch Corporation Information
11.11.2 Chuntch Overview
11.11.3 Chuntch Paclitaxel Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Chuntch Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Chuntch Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Paclitaxel Injection Industry Chain Analysis
12.2 Paclitaxel Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Paclitaxel Injection Production Mode & Process
12.4 Paclitaxel Injection Sales and Marketing
12.4.1 Paclitaxel Injection Sales Channels
12.4.2 Paclitaxel Injection Distributors
12.5 Paclitaxel Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Paclitaxel Injection Industry Trends
13.2 Paclitaxel Injection Market Drivers
13.3 Paclitaxel Injection Market Challenges
13.4 Paclitaxel Injection Market Restraints
14 Key Findings in The Global Paclitaxel Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Paclitaxel Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 5ml,30mg
    Table 3. Major Manufacturers of 10ml,60mg
    Table 4. Major Manufacturers of 16.7ml,100mg
    Table 5. Major Manufacturers of 25ml,150mg
    Table 6. Major Manufacturers of 50ml,300mg
    Table 7. Global Paclitaxel Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Paclitaxel Injection Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Paclitaxel Injection Sales by Region (2017-2022) & (K Units)
    Table 10. Global Paclitaxel Injection Sales Market Share by Region (2017-2022)
    Table 11. Global Paclitaxel Injection Sales by Region (2023-2028) & (K Units)
    Table 12. Global Paclitaxel Injection Sales Market Share by Region (2023-2028)
    Table 13. Global Paclitaxel Injection Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Paclitaxel Injection Revenue Market Share by Region (2017-2022)
    Table 15. Global Paclitaxel Injection Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Paclitaxel Injection Revenue Market Share by Region (2023-2028)
    Table 17. Global Paclitaxel Injection Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Paclitaxel Injection Sales Share by Manufacturers (2017-2022)
    Table 19. Global Paclitaxel Injection Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Paclitaxel Injection Revenue Share by Manufacturers (2017-2022)
    Table 21. Paclitaxel Injection Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Paclitaxel Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Paclitaxel Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel Injection as of 2021)
    Table 24. Paclitaxel Injection Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Paclitaxel Injection Product Offered
    Table 26. Date of Manufacturers Enter into Paclitaxel Injection Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Paclitaxel Injection Sales by Type (2017-2022) & (K Units)
    Table 29. Global Paclitaxel Injection Sales by Type (2023-2028) & (K Units)
    Table 30. Global Paclitaxel Injection Sales Share by Type (2017-2022)
    Table 31. Global Paclitaxel Injection Sales Share by Type (2023-2028)
    Table 32. Global Paclitaxel Injection Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Paclitaxel Injection Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Paclitaxel Injection Revenue Share by Type (2017-2022)
    Table 35. Global Paclitaxel Injection Revenue Share by Type (2023-2028)
    Table 36. Paclitaxel Injection Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Paclitaxel Injection Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Paclitaxel Injection Sales by Application (2017-2022) & (K Units)
    Table 39. Global Paclitaxel Injection Sales by Application (2023-2028) & (K Units)
    Table 40. Global Paclitaxel Injection Sales Share by Application (2017-2022)
    Table 41. Global Paclitaxel Injection Sales Share by Application (2023-2028)
    Table 42. Global Paclitaxel Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Paclitaxel Injection Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Paclitaxel Injection Revenue Share by Application (2017-2022)
    Table 45. Global Paclitaxel Injection Revenue Share by Application (2023-2028)
    Table 46. Paclitaxel Injection Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Paclitaxel Injection Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Paclitaxel Injection Sales by Type (2017-2022) & (K Units)
    Table 49. North America Paclitaxel Injection Sales by Type (2023-2028) & (K Units)
    Table 50. North America Paclitaxel Injection Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Paclitaxel Injection Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Paclitaxel Injection Sales by Application (2017-2022) & (K Units)
    Table 53. North America Paclitaxel Injection Sales by Application (2023-2028) & (K Units)
    Table 54. North America Paclitaxel Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Paclitaxel Injection Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Paclitaxel Injection Sales by Country (2017-2022) & (K Units)
    Table 57. North America Paclitaxel Injection Sales by Country (2023-2028) & (K Units)
    Table 58. North America Paclitaxel Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Paclitaxel Injection Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Paclitaxel Injection Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Paclitaxel Injection Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Paclitaxel Injection Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Paclitaxel Injection Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Paclitaxel Injection Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Paclitaxel Injection Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Paclitaxel Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Paclitaxel Injection Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Paclitaxel Injection Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Paclitaxel Injection Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Paclitaxel Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Paclitaxel Injection Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Paclitaxel Injection Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Paclitaxel Injection Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Paclitaxel Injection Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Paclitaxel Injection Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Paclitaxel Injection Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Paclitaxel Injection Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Paclitaxel Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Paclitaxel Injection Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Paclitaxel Injection Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Paclitaxel Injection Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Paclitaxel Injection Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Paclitaxel Injection Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Paclitaxel Injection Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Paclitaxel Injection Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Paclitaxel Injection Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Paclitaxel Injection Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Paclitaxel Injection Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Paclitaxel Injection Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Paclitaxel Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Paclitaxel Injection Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Paclitaxel Injection Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Paclitaxel Injection Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Paclitaxel Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Paclitaxel Injection Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Paclitaxel Injection Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Paclitaxel Injection Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Paclitaxel Injection Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Paclitaxel Injection Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Paclitaxel Injection Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Paclitaxel Injection Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Paclitaxel Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Paclitaxel Injection Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Paclitaxel Injection Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Paclitaxel Injection Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Paclitaxel Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Paclitaxel Injection Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Bristol-Myers Squibb Corporation Information
    Table 109. Bristol-Myers Squibb Description and Major Businesses
    Table 110. Bristol-Myers Squibb Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Bristol-Myers Squibb Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Bristol-Myers Squibb Recent Developments
    Table 113. Celgene Corporation Corporation Information
    Table 114. Celgene Corporation Description and Major Businesses
    Table 115. Celgene Corporation Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Celgene Corporation Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Celgene Corporation Recent Developments
    Table 118. Hospira Corporation Information
    Table 119. Hospira Description and Major Businesses
    Table 120. Hospira Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Hospira Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Hospira Recent Developments
    Table 123. Biological E. Corporation Information
    Table 124. Biological E. Description and Major Businesses
    Table 125. Biological E. Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. Biological E. Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Biological E. Recent Developments
    Table 128. Taj Accura Corporation Information
    Table 129. Taj Accura Description and Major Businesses
    Table 130. Taj Accura Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. Taj Accura Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Taj Accura Recent Developments
    Table 133. Khandelwal Laboratories Corporation Information
    Table 134. Khandelwal Laboratories Description and Major Businesses
    Table 135. Khandelwal Laboratories Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Khandelwal Laboratories Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Khandelwal Laboratories Recent Developments
    Table 138. Luye Pharma Corporation Information
    Table 139. Luye Pharma Description and Major Businesses
    Table 140. Luye Pharma Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Luye Pharma Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Luye Pharma Recent Developments
    Table 143. Beijing Youcare Corporation Information
    Table 144. Beijing Youcare Description and Major Businesses
    Table 145. Beijing Youcare Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. Beijing Youcare Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Beijing Youcare Recent Developments
    Table 148. Beijing Union Corporation Information
    Table 149. Beijing Union Description and Major Businesses
    Table 150. Beijing Union Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. Beijing Union Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Beijing Union Recent Developments
    Table 153. Haiyao Corporation Information
    Table 154. Haiyao Description and Major Businesses
    Table 155. Haiyao Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 156. Haiyao Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Haiyao Recent Developments
    Table 158. Chuntch Corporation Information
    Table 159. Chuntch Description and Major Businesses
    Table 160. Chuntch Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 161. Chuntch Paclitaxel Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Chuntch Recent Developments
    Table 163. Key Raw Materials Lists
    Table 164. Raw Materials Key Suppliers Lists
    Table 165. Paclitaxel Injection Distributors List
    Table 166. Paclitaxel Injection Customers List
    Table 167. Paclitaxel Injection Market Trends
    Table 168. Paclitaxel Injection Market Drivers
    Table 169. Paclitaxel Injection Market Challenges
    Table 170. Paclitaxel Injection Market Restraints
    Table 171. Research Programs/Design for This Report
    Table 172. Key Data Information from Secondary Sources
    Table 173. Key Data Information from Primary Sources
List of Figures
    Figure 1. Paclitaxel Injection Product Picture
    Figure 3. Global Paclitaxel Injection Market Share by Type in 2021 & 2028
    Figure 3. 5ml,30mg Product Picture
    Figure 4. 10ml,60mg Product Picture
    Figure 5. 16.7ml,100mg Product Picture
    Figure 6. 25ml,150mg Product Picture
    Figure 7. 50ml,300mg Product Picture
    Figure 8. Global Paclitaxel Injection Market Share by Application in 2021 & 2028
    Figure 9. Ovarian Cancer
    Figure 10. Breast Cancer
    Figure 11. Cervical Cancer
    Figure 12. Pancreatic Cancer
    Figure 13. Other
    Figure 14. Paclitaxel Injection Report Years Considered
    Figure 15. Global Paclitaxel Injection Sales 2017-2028 (K Units)
    Figure 16. Global Paclitaxel Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Paclitaxel Injection Revenue 2017-2028 (US$ Million)
    Figure 18. Global Paclitaxel Injection Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Paclitaxel Injection Sales Market Share by Region (2017-2022)
    Figure 20. Global Paclitaxel Injection Sales Market Share by Region (2023-2028)
    Figure 21. North America Paclitaxel Injection Sales YoY (2017-2028) & (K Units)
    Figure 22. North America Paclitaxel Injection Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Paclitaxel Injection Sales YoY (2017-2028) & (K Units)
    Figure 24. Europe Paclitaxel Injection Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Paclitaxel Injection Sales YoY (2017-2028) & (K Units)
    Figure 26. Asia-Pacific Paclitaxel Injection Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Paclitaxel Injection Sales YoY (2017-2028) & (K Units)
    Figure 28. Latin America Paclitaxel Injection Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Paclitaxel Injection Sales YoY (2017-2028) & (K Units)
    Figure 30. Middle East & Africa Paclitaxel Injection Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Paclitaxel Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Paclitaxel Injection in the World: Market Share by Paclitaxel Injection Revenue in 2021
    Figure 33. Global Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Paclitaxel Injection Sales Market Share by Type (2017-2028)
    Figure 35. Global Paclitaxel Injection Revenue Market Share by Type (2017-2028)
    Figure 36. Global Paclitaxel Injection Sales Market Share by Application (2017-2028)
    Figure 37. Global Paclitaxel Injection Revenue Market Share by Application (2017-2028)
    Figure 38. North America Paclitaxel Injection Sales Market Share by Type (2017-2028)
    Figure 39. North America Paclitaxel Injection Revenue Market Share by Type (2017-2028)
    Figure 40. North America Paclitaxel Injection Sales Market Share by Application (2017-2028)
    Figure 41. North America Paclitaxel Injection Revenue Market Share by Application (2017-2028)
    Figure 42. North America Paclitaxel Injection Sales Share by Country (2017-2028)
    Figure 43. North America Paclitaxel Injection Revenue Share by Country (2017-2028)
    Figure 44. U.S. Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Paclitaxel Injection Sales Market Share by Type (2017-2028)
    Figure 47. Europe Paclitaxel Injection Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Paclitaxel Injection Sales Market Share by Application (2017-2028)
    Figure 49. Europe Paclitaxel Injection Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Paclitaxel Injection Sales Share by Country (2017-2028)
    Figure 51. Europe Paclitaxel Injection Revenue Share by Country (2017-2028)
    Figure 52. Germany Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 53. France Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Paclitaxel Injection Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Paclitaxel Injection Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Paclitaxel Injection Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Paclitaxel Injection Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Paclitaxel Injection Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Paclitaxel Injection Revenue Share by Region (2017-2028)
    Figure 63. China Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 66. India Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 68. China Taiwan Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Paclitaxel Injection Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Paclitaxel Injection Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Paclitaxel Injection Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Paclitaxel Injection Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Paclitaxel Injection Sales Share by Country (2017-2028)
    Figure 77. Latin America Paclitaxel Injection Revenue Share by Country (2017-2028)
    Figure 78. Mexico Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Paclitaxel Injection Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Paclitaxel Injection Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Paclitaxel Injection Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Paclitaxel Injection Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Paclitaxel Injection Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Paclitaxel Injection Revenue Share by Country (2017-2028)
    Figure 87. Turkey Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 89. UAE Paclitaxel Injection Revenue (2017-2028) & (US$ Million)
    Figure 90. Paclitaxel Injection Value Chain
    Figure 91. Paclitaxel Injection Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Risperidone Market Insights and Forecast to 2028
Global and United States Risperidone Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-34S6889
Mon Nov 07 00:00:00 UTC 2022

Add to Cart

Global Erythropoietin ELISA Test Kit Market Research Report 2022
Global and United States Erythropoietin ELISA Test Kit Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-32I12133
Mon Nov 07 00:00:00 UTC 2022

Add to Cart

Global Synthetic Bioinks Market Research Report 2022
Global and United States Synthetic Bioinks Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-15I12294
Mon Nov 07 00:00:00 UTC 2022

Add to Cart

Global Fluorinated Pharmaceutical Intermediates Market Research Report 2022
Global Fluorinated Pharmaceutical Intermediates Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-18A12300
Thu Nov 03 00:00:00 UTC 2022

Add to Cart